Status:

NOT_YET_RECRUITING

Efficacy of Letermovir in Preventing Cytomegalovirus (CMV) Infection in Lung Transplant Recipients vs. Valganciclovir.

Lead Sponsor:

Maimónides Biomedical Research Institute of Córdoba

Collaborating Sponsors:

MERCK SHARP & DOHME DE ESPAÑA S.A.

Conditions:

Infections, Cytomegalovirus

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The goal of this quasi-experimental multicenter before-after cohort study, phase II study is to evaluate the efficacy of 12-month letermovir prophylaxis in lung transplant recipients (D+/R-) compared ...

Eligibility Criteria

Inclusion

  • Inclusion Criteria (prospective cohort):
  • Adults over 18 years old
  • Lung transplant recipients (D+/R-) pre-transplant.
  • Having an undetectable CMV polymerase chain reaction assay (PCR) within the 96 hours prior to the start of letermovir prophylaxis.
  • Patients who have provided written informed consent.
  • Exclusion Criteria (prospective cohort):
  • HIV-infected patients.
  • Patients with multivisceral transplant.
  • Patients unable to comply with the follow-up protocol.
  • Receiving a different antiviral prophylaxis other than ganciclovir prior to letermovir prophylaxis.
  • Patients with concurrent renal and hepatic insufficiency.
  • Inclusion Criteria (retrospective cohort):
  • Adults over 18 years old. Lung transplant recipients (D+/R-) pre-transplant.
  • Patients treated with Valganciclovir prophylaxis for 12 months.
  • Patients transplanted within 2 years prior to the start of the study.
  • Patients with a complete 13-month follow-up and comparable data to the prospective cohort to evaluate the study's primary variables.
  • Exclusion Criteria (retrospective cohort):
  • HIV-infected patients.
  • Patients with multivisceral transplant.

Exclusion

    Key Trial Info

    Start Date :

    October 1 2023

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    April 1 2027

    Estimated Enrollment :

    90 Patients enrolled

    Trial Details

    Trial ID

    NCT06057194

    Start Date

    October 1 2023

    End Date

    April 1 2027

    Last Update

    September 28 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Hospital Universitario Reina Sofia

    Córdoba, Córdoba, Spain, 14004